Registry for African Americans With Early Rheumatoid Arthritis
CLEAR
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)
2 other identifiers
observational
357
1 country
5
Brief Summary
The purpose of this study is to better understand the causes of rheumatoid arthritis (RA), particularly in African Americans.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2001
Longer than P75 for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2001
CompletedFirst Submitted
Initial submission to the registry
December 16, 2003
CompletedFirst Posted
Study publicly available on registry
December 17, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2012
CompletedJanuary 6, 2016
January 1, 2016
10.9 years
December 16, 2003
January 5, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Radiographic severity of rheumatoid arthritis in African Americans
Initially seen at 5 yr disease duration. Later, became a cross-sectional (1 time visit).
5 yr disease duration
Eligibility Criteria
African Americans
You may qualify if:
- African American
- Rheumatoid arthritis for less than 2 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
Emory University
Atlanta, Georgia, 30303, United States
Washington University at St. Louis
St Louis, Missouri, 63130, United States
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Biospecimen
serum, DNA
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
S. Louis Bridges, Jr., MD, PhD
University of Alabama at Birmingham
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 16, 2003
First Posted
December 17, 2003
Study Start
January 1, 2001
Primary Completion
December 1, 2011
Study Completion
March 1, 2012
Last Updated
January 6, 2016
Record last verified: 2016-01